Dr. Aaron M. Perlmutter, MD

Dr. Perlmutter practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Perlmutter's NPI, 1114952496, was assigned on July 12, 2006. Dr. Perlmutter graduated from Boston University School Of Medicine in 1996. Dr. Perlmutter holds California license A70055.

Dr. Perlmutter's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Perlmutter's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Woundtech of California. Dmand AI also links Dr. Perlmutter to 2 more home health agencies and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Perlmutter practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Perlmutter's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Perlmutter's licenses on file in 6 states: California, Oregon, District of Columbia, Hawaii, Virginia and Washington.

Dmand AI lists hiv/aids, joint or bone infection, pneumonia, UTI and yeast infection among the conditions Dr. Perlmutter treats.

CMS data shows 16,308 Medicare services from Dr. Perlmutter across 9 procedure codes in 2024, for 448 Medicare patients. Medicare paid $492,528 for them.

CMS counts 448 Medicare patients who saw Dr. Perlmutter in 2024. The largest group is 65 to 74, with 165 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 63% are also on Medicaid. Their average risk score is 3.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Perlmutter's median patient age at 65, with 37% women.

In 2024, Dr. Perlmutter wrote 3,606 Medicare Part D claims for 137 patients. 74% of them were for generic drugs. CMS names the drug for 3,117 of them, across 97 drugs with 11 or more claims each, at $3,212,697 in total drug cost. In 2023, CMS named 3,403 claims across 106 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Perlmutter for performance year 2024, reported individually. Dr. Perlmutter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Perlmutter as offering telehealth.

CMS Open Payments shows 772 general payments to Dr. Perlmutter from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. Gilead Sciences, Inc. paid the most, $7,308.

Dmand AI lists 1 award for Dr. Perlmutter, most recently CMS Stage 1 EHR in 2013.

Dr. Perlmutter graduated from Boston University School Of Medicine in 1996.

Dr. Perlmutter is in network with 16 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.